WPG Advisers
RVMD icon

WPG Advisers’s Revolution Medicines RVMD Stock Holding History

WPG Advisers’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.87K Buy
14
+13
+1,300% +$2.58K ﹤0.01% 1089
2026
Q2 		$187 Buy
+1
New +$146 ﹤0.01% 1505
2025
Q1 		– Sell
-46
Closed -$2.01K – 1523
2024
Q4 		$2.01K Buy
+46
New +$2.32K ﹤0.01% 1077

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return

WPG Advisers's RVMD Position: Q3 2026 in Review

WPG Advisers increased its Revolution Medicines (RVMD) stake by 1,300% in Q3 2026, buying an estimated $2.58K and bringing the position to 14 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1089.

WPG Advisers first reported a position in RVMD in Q4 2024 and has held it in 3 quarters since. 577 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • WPG Advisers held 14 shares of Revolution Medicines worth $2.87K as of Q3 2026.
  • WPG Advisers bought 13 Revolution Medicines shares in Q3 2026, an estimated $2.58K.
  • Revolution Medicines made up ﹤0.01% of WPG Advisers's portfolio in Q3 2026, its #1089 holding.
  • WPG Advisers first reported a position in Revolution Medicines in Q4 2024 and has held it in 3 quarters since.
  • 577 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on WPG Advisers's 13F filing for Q3 2026, filed 27 Oct 2026.